V009-0251 Screening compound: N-[2-(4-fluorophenyl)ethyl]-4-methoxy-3-[4-(2-phenoxypropanoyl)piperazin-1-yl]benzene-1-sulfonamide

V009-0251 Screening compound: N-[2-(4-fluorophenyl)ethyl]-4-methoxy-3-[4-(2-phenoxypropanoyl)piperazin-1-yl]benzene-1-sulfonamide
V009-0251 Screening compound: N-[2-(4-fluorophenyl)ethyl]-4-methoxy-3-[4-(2-phenoxypropanoyl)piperazin-1-yl]benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-0251
N-[2-(4-fluorophenyl)ethyl]-4-methoxy-3-[4-(2-phenoxypropanoyl)piperazin-1-yl]benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-0251

Molecular Formula

C28H32FN3O5S (C28 H32 FN3 O5 S)

Compound Name

N-[2-(4-fluorophenyl)ethyl]-4-methoxy-3-[4-(2-phenoxypropanoyl)piperazin-1-yl]benzene-1-sulfonamide

IUPAC name

N-[2-(4-fluorophenyl)ethyl]-4-methoxy-3-[4-(2-phenoxypropanoyl)piperazin-1-yl]benzene-1-sulfonamide

SMILES

CC(C(N(CC1)CCN1c(cc(cc1)S(NCCc(cc2)ccc2F)(=O)=O)c1OC)=O)Oc1ccccc1

InChI

InChI=1S/C28H32FN3O5S/c1-21(37-24-6-4-3-5-7-24)28(33)32-18-16-31(17-19-32)26-20-25(12-13-27(26)36-2)38(34,35)30-15-14-22-8-10-23(29)11-9-22/h3-13,20-21,30H,14-19H2,1-2H3/t21-/m0/s1

InChI Key

BSGOHEMDKOIXGB-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19950736

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

541.64

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.369

Distribution Coefficient, logD

4.368

Water Solubility, LogSw

-4.26

Polar Surface Area

75.865

Acid Dissociation Constant (pKa)

11.77

Base Dissociation Constant (pKb)

2.90

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.10

V009-0251 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V009-0251 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-0251?
Check Price and Availability of V009-0251, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-0251 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-0251
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-0251
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-0251 available by request